Swiss Life Sciences Trend Analysis 2013

Swiss Biotech financings were weaker in 2012 with only USD 117 M being raised. In the same period the number of companies increased by 9% – primarily companies in therapeutics and R&D services. Click here to download Swiss Life Sciences Trend Analysis 2013 – 12 pages Looking for your next Biotech or Medtech partner? Use … Continue reading Swiss Life Sciences Trend Analysis 2013

Read more